Addrenex Pharmaceuticals Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$29M
Addrenex Pharmaceuticals General Information
Description
The company is currently operating in Stealth mode.
Contact Information
Corporate Office
- 4825 Creekstone Drive
- Suite 100
- Durham, NC 27703
- United States
Corporate Office
- 4825 Creekstone Drive
- Suite 100
- Durham, NC 27703
- United States
Addrenex Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 13-Nov-2009 | $29M | Completed | Generating Revenue | ||
| 1. Early Stage VC | Completed | Generating Revenue |
Addrenex Pharmaceuticals Patents
Addrenex Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2008261957-A1 | Extended release formulation and method of treating adrenergic dysregulation | Inactive | 08-Jun-2007 | ||
| CA-2689978-A1 | Extended release formulation and method of treating adrenergic dysregulation | Inactive | 08-Jun-2007 | ||
| EP-2155170-A2 | Extended release formulation and method of treating adrenergic dysregulation | Inactive | 08-Jun-2007 | ||
| WO-2008154339-A2 | Extended release formulation and method of treating adrenergic dysregulation | Inactive | 08-Jun-2007 | ||
| WO-2008154339-A3 | Extended release formulation and method of treating adrenergic dysregulation | Inactive | 08-Jun-2007 | A61K9/2018 |
Addrenex Pharmaceuticals Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Solas BioVentures | Venture Capital | Minority |
Addrenex Pharmaceuticals FAQs
-
When was Addrenex Pharmaceuticals founded?
Addrenex Pharmaceuticals was founded in 2006.
-
Where is Addrenex Pharmaceuticals headquartered?
Addrenex Pharmaceuticals is headquartered in Durham, NC.
-
What industry is Addrenex Pharmaceuticals in?
Addrenex Pharmaceuticals’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Addrenex Pharmaceuticals a private or public company?
Addrenex Pharmaceuticals is a Private company.
-
What is the current valuation of Addrenex Pharmaceuticals?
The current valuation of Addrenex Pharmaceuticals is .
-
What is Addrenex Pharmaceuticals’s current revenue?
The current revenue for Addrenex Pharmaceuticals is .
-
Who are Addrenex Pharmaceuticals’s investors?
Solas BioVentures has invested in Addrenex Pharmaceuticals.
-
When was Addrenex Pharmaceuticals acquired?
Addrenex Pharmaceuticals was acquired on 13-Nov-2009.
-
Who acquired Addrenex Pharmaceuticals?
Addrenex Pharmaceuticals was acquired by Sciele Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process